Loading…

Evidence of LMP1–TRAF3 interactions in glycosphingolipid‐rich complexes of lymphoblastoid and nasopharyngeal carcinoma cells

Latent membrane protein 1 (LMP1) is an Epstein‐Barr virus (EBV) protein expressed in EBV‐transformed B lymphocytes and in approximately 50% of nasopharyngeal carcinomas (NPCs). LMP1 signaling involves several cellular signaling intermediates, especially TNF receptor–associated factors (TRAFs). We ha...

Full description

Saved in:
Bibliographic Details
Published in:International journal of cancer 1999-05, Vol.81 (4), p.645-649
Main Authors: Ardila‐Osorio, Hector, Clausse, Bernard, Mishal, Zohair, Wiels, Joëlle, Tursz, Thomas, Busson, Pierre
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Latent membrane protein 1 (LMP1) is an Epstein‐Barr virus (EBV) protein expressed in EBV‐transformed B lymphocytes and in approximately 50% of nasopharyngeal carcinomas (NPCs). LMP1 signaling involves several cellular signaling intermediates, especially TNF receptor–associated factors (TRAFs). We have shown previously that LMP1 is highly concentrated in a cell fraction called glycosphingolipid‐rich membrane complexes (GSL complexes). We report here that parallel accumulation of LMP1 and TRAF3, but not TRAF1 or TRADD, was observed in GSL complexes from lymphoblastoid and LMP1‐positive NPC cells. In contrast, TRAF3 was not concentrated in GSL complexes from LMP1‐negative cells. Binding of LMP1 and TRAF3 in GSL complexes was demonstrated in lymphoblastoid and NPC cells, by co‐immunoprecipitation with both anti‐LMP1 and anti‐TRAF3 antibodies. Int. J. Cancer 81:645–649, 1999. © 1999 Wiley‐Liss, Inc.
ISSN:0020-7136
1097-0215
DOI:10.1002/(SICI)1097-0215(19990517)81:4<645::AID-IJC22>3.0.CO;2-0